Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants Post author: Post published: Post category:Uncategorized Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants You Might Also Like Agenda – System demo Q4 2022 Agenda – COMP agenda of the 13-15 July 2021 meeting Agenda – First industry standing group (ISG) meeting
